orlistat and Thrombocytopenia

orlistat has been researched along with Thrombocytopenia* in 1 studies

Other Studies

1 other study(ies) available for orlistat and Thrombocytopenia

Article	Year
Example of the drug interaction between ciclosporin and orlistat, resulting in relapse of Evan's syndrome. BMJ case reports, 2016, Oct-28, Volume: 2016 A man aged 35 years with a history of Evan's syndrome presented to the clinic with jaundice and shortness of breath, with further testing indicating a relapse of his previously well-controlled condition, for which he was taking ciclosporin. This followed shortly after he had started taking orlistat to prevent weight gain from a course of steroids, and once the orlistat was stopped, his platelets began to rise. The patient required 4 months of steroid treatment before his platelet levels finally stabilised and he could be put back on his regular medicine regime. Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Obesity Agents; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Lactones; Male; Orlistat; Recurrence; Thrombocytopenia	2016

Article

Year

Example of the drug interaction between ciclosporin and orlistat, resulting in relapse of Evan's syndrome.

BMJ case reports, 2016, Oct-28, Volume: 2016

A man aged 35 years with a history of Evan's syndrome presented to the clinic with jaundice and shortness of breath, with further testing indicating a relapse of his previously well-controlled condition, for which he was taking ciclosporin. This followed shortly after he had started taking orlistat to prevent weight gain from a course of steroids, and once the orlistat was stopped, his platelets began to rise. The patient required 4 months of steroid treatment before his platelet levels finally stabilised and he could be put back on his regular medicine regime.

Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Obesity Agents; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Lactones; Male; Orlistat; Recurrence; Thrombocytopenia

2016